Quick Answer
Ernexa Therapeutics Inc. reported Gross Profit of $486.0 thousand for fiscal year 2024.
Ernexa Therapeutics Inc. Gross Profit — Annual History
| Fiscal Year | Gross Profit | YoY Change |
|---|---|---|
| 2024 | $486.0K | +389.3% |
| 2023 | -$168.0K | — |
| 2022 | $0.00 | — |
Quarterly Gross Profit
| Quarter Ending | Gross Profit | YoY | QoQ |
|---|---|---|---|
| September 30, 2024 | $547.0K | +892.8% | +1239.6% |
| June 30, 2024 | -$48.0K | — | -242.9% |
| March 31, 2024 | -$14.0K | +72.0% | +79.7% |
| September 30, 2023 | -$69.0K | — | -38.0% |
| March 31, 2023 | -$50.0K | — | — |
| September 30, 2022 | $0.00 | — | — |
- Ernexa Therapeutics Inc. showed an increase of +389.3% in Gross Profit compared to the prior fiscal year.
- The most recent figure is from Ernexa Therapeutics Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 13, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: